QFT-Plus Knowledge Hub
QFT-Plus Webinar Hub

Learn about TB testing from the experts

TB screening with confidence

Welcome to the webinar hub for QuantiFERON-TB Gold Plus (QFT-Plus) and TB testing.

The US CDC now recommends TB blood tests, like QFT-Plus, for the majority of the US testing population (1). Doctors and hospitals trust QFT-Plus to provide accurate, cost-effective testing in a single patient visit.

To learn more about the benefits of QFT-Plus testing and hear about the latest testing guidelines from the CDC, IDSA, USCIS and more, watch our most recent webinars.

  • QuantiFERON-TB Gold Plus: Is your practice up to date?
    Recent publications show the potential of QFT-Plus technology for at-risk patient populations — including contact investigation, healthcare worker screening and immunocompromised patients. In this webinar, Dr. Masae Kawamura discusses the latest scientific advancements in TB testing, including a review of recent publications and a discussion of case scenarios applying the insights of QFT-Plus.
    QuantiFERON-TB Gold Plus: Is your practice up to date?
  • Tuberculosis testing for healthcare providers in the age of COVID-19
    Join Dr. Wendy Thanassi as she provides an overview of the impact of the COVID-19 pandemic on TB incidence, U.S. public health data on TB and LTBI and major U.S. healthcare policy guidelines. She also discusses the role of IGRA and LTBI treatment in these challenging times.
    Thanassi Wendy
  • Risk-based TB screening: a primary care approach to TB elimination
    QFT-Plus features innovative CD8 T cell technology that provides clinicians with a more comprehensive picture of a patient’s immune response to TB. Join Dr. Alawode Oladele as he describes the importance of latent TB testing in the US. Dr. Oladele focuses on the benefits of modern TB blood testing with QuantiFERON-TB Gold Plus.
    Risk-based TB screening: a primary care approach to TB elimination
  • Protecting students from TB – best practices in proactive screening and contact investigations
    People living in dense housing arrangements – such as college dormitories – are at significantly increased risk of TB infection. Dr. Sonia Qasba describes recent TB exposures at US colleges, details testing recommendations from the ACHA and the CDC and describes how modern TB blood testing can improve the effectiveness and efficiency of college screening programs.
    Protecting students from TB – best practices in proactive screening and contact investigations
  • Best practices in tuberculosis screening and prevention in long-term care facilities
    More than 25% of TB cases in the USA occur in individuals over the age of 65. National guidelines from the US Preventive Services Task Force now recommend the screening of all persons entering congregate settings for latent TB infection. Watch the on-demand webinar where Dr. Sonia Qasba provides an overview of the best practices for TB screening in long-term care facilities.
    Best practices in tuberculosis screening and prevention in long-term care facilities
  • Understanding the USCIS TB testing guidelines for immigrations exams
    As of October 1, 2018, the USCIS is no longer accepting the tuberculin skin test (TST) for US immigration exams. Instead, a TB blood test (interferon-gamma release assay or IGRA) is required for permanent resident applicants. View the on-demand webinar where Dr. Alawode Oladele introduces the new IGRA requirement and the updated technical instructions.
    Understanding the USCIS TB testing guidelines for immigrations exams
  • Advancing healthcare personnel TB screening: new national guidelines and QuantiFERON-TB Gold Plus
    Healthcare providers are at increased risk for TB, and CDC has released updated tuberculosis testing guidelines for healthcare providers (HCPs) in the US. In this webinar, Dr. Masae Kawamura introduces the new national testing guidelines, the scientific rationale for change and their implications for healthcare facilities and occupational health programs.
    Advancing healthcare personnel TB screening: new national guidelines and QuantiFERON-TB Gold Plus
  • Combating the threat of TB in correctional facilities
    Correctional facilities play a critical role in controlling TB. In this webinar, Dr. Masae Kawamura discusses recent policy advancements that are helping prevent tuberculosis in jails and prisons. You’ll learn about the latest diagnostic tools for TB infection as well as new preventative treatment regimens that are increasing compliance and decreasing cost.
    Understanding the USCIS TB testing guidelines for immigrations exams
  • Management of latent TB infection in patients requiring initiation of biologic therapy
    Join Dr. Vlad Nikolayevskyy as he provides an overview of the policies, practices and recent publications on screening patients requiring initiation of biologic therapy for TB infection. He also discusses new preventive treatment regimens and the use of IGRAs as a primary screening method.
    Manage latent TB infection prior to biologic therapy
  • Managing TB and HIV amidst the COVID-19 pandemic
    The COVID-19 pandemic has caused a global crisis with wide-reaching health and economic implications, including TB and HIV services. Join Dr. Sonia Qasba as she reviews screening for TB infection and prevention during these times, along with U.S. and global trends in COVID-19 epidemiology.
    Managing TB and HIV amidst the COVID-19 pandemic
  • QuantiFERON-TB Gold Plus: Is your practice up to date?
    QuantiFERON-TB Gold Plus: Is your practice up to date?
  • Thanassi Wendy
    Tuberculosis testing for healthcare providers in the age of COVID-19
  • Risk-based TB screening: a primary care approach to TB elimination
    Risk-based TB screening: a primary care approach to TB elimination
  • Protecting students from TB – best practices in proactive screening and contact investigations
    Protecting students from TB – best practices in proactive screening and contact investigations
  • Best practices in tuberculosis screening and prevention in long-term care facilities
    Best practices in tuberculosis screening and prevention in long-term care facilities
  • Understanding the USCIS TB testing guidelines for immigrations exams
    Understanding the USCIS TB testing guidelines for immigrations exams
  • Advancing healthcare personnel TB screening: new national guidelines and QuantiFERON-TB Gold Plus
    Advancing healthcare personnel TB screening: new national guidelines and QuantiFERON-TB Gold Plus
  • Understanding the USCIS TB testing guidelines for immigrations exams
    Combating the threat of TB in correctional facilities
  • Manage latent TB infection prior to biologic therapy
    Management of latent TB infection in patients requiring initiation of biologic therapy
  • Managing TB and HIV amidst the COVID-19 pandemic
    Managing TB and HIV amidst the COVID-19 pandemic

References:

1. Lewinsohn, et al. (2017) Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin. Infect. Dis. 64, 111–115.

QFT-Plus is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. The USA format of the QFT-Plus test has not been extensively evaluated with specimens from individuals who have impaired or altered immune functions, such as those who have HIV infection or AIDS, those who have transplantation managed with immunosuppressive treatment or others who receive immunosuppressive drugs (e.g., corticosteroids, methotrexate, azathioprine, cancer chemotherapy), those who have other clinical conditions, such as diabetes, silicosis, chronic renal failure, and hematological disorders (e.g., leukemia and lymphomas), or those with other specific malignancies (e.g., carcinoma of the head or neck and lung), or individuals younger than age 17 years. QFT-Plus package inserts, up-to-date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com

X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm